Product Information
AMIODARONE HCL 200 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1218 per EA under NDC 51672402504. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Mar 30, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Amiodarone Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672402504
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMIODARONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075424FDA Approved
3/30/2001
TE Code
AB
On Market Since
3/30/2001
Pharmacological Classes
Price Statistics
The NADAC for AMIODARONE HCL 200 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 11.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1218 per EA |
|---|---|
| All-time high | $0.1748 (Jul 16, 2014) |
| All-time low | $0.0989 (Nov 20, 2024) |
| 52-week high | $0.1227 |
| 52-week low | $0.1160 |
| Median price | $0.1301 |
| Average price | $0.1309 |
| Largest weekly change | -17.6% (Apr 17, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amiodarone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMIODARONE HCL 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AMIODARONE HCL 200 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.1218 per EA (NDC 51672402504), effective Sep 30, 2026.
How has the price of AMIODARONE HCL 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for AMIODARONE HCL 200 MG TABLET has declined 11.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AMIODARONE HCL 200 MG TABLET?
Since Nov 28, 2013, the NADAC for AMIODARONE HCL 200 MG TABLET has ranged from a low of $0.0989 (Nov 20, 2024) to a high of $0.1748 (Jul 16, 2014), with a median of $0.1301 per EA.
Are there cheaper alternatives to AMIODARONE HCL 200 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMIODARONE HCL 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures AMIODARONE HCL 200 MG TABLET?
AMIODARONE HCL 200 MG TABLET (NDC 51672402504) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.